Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mach7 Technologies.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?
Experts
Scopo’s powerplays: Healthcare steadies, and Mach7 ‘looks really interesting’
Experts
ScoPo’s health powerplays: What to look for this earnings season
Health & Biotech
Medical imaging company Singular Health’s $6m IPO triggers investor stampede
News
Last Orders: Large caps gain 0.52 per cent, small caps finish the day flat
Experts
ScoPo’s powerplays: Market hit by profit-taking, but healthcare outperforms
News
Last Orders: Small caps hit another 12-year high ahead of holiday
Health & Biotech
TGA approves Pfizer jab; Nyrada, Mach7 hit all-time high
Experts
ScoPo’s powerplays: Bullish on mobile X-ray company Micro-X
News
ScoPo’s powerplays: Morgans’ healthcare picks for 2021
Experts
ScoPo’s powerplays: ‘It’s a new dawn… get in front of these extraordinary opportunities’
Experts
ScoPo’s powerplays: ‘It’s going to be a great run into 2021’
Health & Biotech
Dr Boreham’s Crucible: The bigger picture finally appears for Mach7 Technologies
Experts
Scopo’s health powerplays: A healthy earnings season
Experts
Scopo’s health powerplays: quick vaccine hits and cheap buys
Experts
Scopo’s health powerplays: The cash caboose keeps rolling on
Experts
